<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Mechanism of action of angiotensin receptor-neprilysin inhibitor​</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Mechanism of action of angiotensin receptor-neprilysin inhibitor​</h1>
<div class="graphic"><div class="figure"><div class="ttl">Mechanism of action of angiotensin receptor-neprilysin inhibitor​</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">Neprilysin, a neutral endopeptidase, degrades vasoactive neurohormones including natriuretic peptides, bradykinin, and adrenomedullin. Neprilysin also degrades angiotensin II. When a pure neprilysin inhibitor is administered, it prevents the degradation of these peptides, leading to an increase in the neurohormones that exert favorable effects (eg, natriuretic peptides) but also an increase in angiotensin II, which exerts detrimental effects. The up arrows depict the increase in angiotensin II levels resulting from neprilysin inhibition. In order to mitigate the effects of elevated angiotensin II levels, a strategy has emerged to combine a neprilysin inhibitor with an angiotensin receptor blocker. This class of agents is called ARNI, an abbreviation for angiotensin receptor-neprilysin inhibitor. In this manner, the deleterious effect of increased angiotensin II levels is prevented by preventing angiotensin II from interacting with its type 1 receptor, while the favorable effects of neprlysin inhibition can accrue. Because both neprilysin inhibitors and ACE inhibitors increase bradykinin, and bradykinin leads to angioedema, administration of a neprilysin inhibitor within 36 hours of administration of an ACE inhibitor is contraindicated, as this combination can result in an unacceptably high incidence of angioedema.</div><div class="graphic_footnotes">BNP: brain natriuretic peptide; ANP: atrial natriuretic peptide; CNP: C-type natriuretic peptide; Ang II: angiotensin II; ARB: angiotensin receptor blocker; SNS: sympathetic nervous system; NEP: neprilysin; ACE: angiotensin-converting enzyme.</div><div id="graphicVersion">Graphic 112675 Version 3.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
